The University of Saskatchewan’s Vaccine and Infectious Disease Organization has announced that construction on its Vaccine Development Centre (VDC) is now complete. USask says that the centre is the largest containment facility in Canada, and that it will expand Canada’s ability to respond to future pandemics. The facility will be able to develop human and animal vaccines for viruses that are categorized up to Level 3. “The construction completion of the Vaccine Development Centre marks a major milestone for VIDO and its role as a global leader in addressing COVID-19 and future infectious disease outbreaks,” said USask President Peter Stoicheff. “We celebrate the partnerships and investment that have led to this moment, empowering USask’s pursuit to be the university the world needs.” USask| CBC Note: Archived stories may contain dead links or be missing source links.